Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
Shannon Burke, Amy L. Shergold, Matthew J. Elder, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 6, pp. 1015-1027
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman, Jill M. Fritz, Michael J. Lenardo
Nature reviews. Immunology (2020) Vol. 20, Iss. 11, pp. 651-668
Open Access | Times Cited: 3194
Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
Bharat Burman, Giulio Pesci, Dmitriy Zamarin
Cancers (2020) Vol. 12, Iss. 12, pp. 3552-3552
Open Access | Times Cited: 77
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 14
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing
Cristina Belgiovine, Elisabeth Digifico, Clément Anfray, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3226-3226
Open Access | Times Cited: 61
Cytokines in oncolytic virotherapy
Jonathan Pol, Samuel T. Workenhe, Prathyusha Konda, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 56, pp. 4-27
Open Access | Times Cited: 52
Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective
Paola Allavena, Clément Anfray, Aldo Ummarino, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 12, pp. 3291-3297
Open Access | Times Cited: 49
The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy
Huiming Yang, Jiaxin Tian, Ye Zhao, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 886-886
Open Access | Times Cited: 7
Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
Fang Huang, Chuan-Jing Dai, You-Ni Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 23
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Zhen Shen, Xiyu Liu, Fan Guixiang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Generation and characterization of chicken monocyte-derived dendritic cells
Elie Ngantcha Tatchou, Romane Milcamps, Guillaume Oldenhove, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements
Ketao Jin, Wenlin Du, Yu‐Yao Liu, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 588-588
Open Access | Times Cited: 29
Current strategies in engaging oncolytic viruses with antitumor immunity
Drew Boagni, Divya Ravirala, Xiaoliu Zhang
Molecular Therapy — Oncolytics (2021) Vol. 22, pp. 98-113
Open Access | Times Cited: 28
Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy
Marc Lecoultre, Paul R. Walker, Aya El Helali
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
Annalisa Chianese, Biagio Santella, Annalisa Ambrosino, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2761-2761
Open Access | Times Cited: 26
The role of extratumoral and intratumoral microorganisms in cancer immunotherapy
Yurong Du, Lei Liu, Wang Ma, et al.
The Innovation Life (2023) Vol. 1, Iss. 2, pp. 100016-100016
Open Access | Times Cited: 10
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Robin Park, Fariha Eshrat, Mohammed Al‐Jumayli, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 447-447
Open Access | Times Cited: 26
Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus
Qiuxing Meng, Jian He, Liping Zhong, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 11, pp. 2294-2302
Open Access | Times Cited: 21
Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
Junfeng Liu, Raziye Piranlioglu, Fei Ye, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Newcastle Disease Virus Inhibits the Proliferation of T Cells Induced by Dendritic Cells In Vitro and In Vivo
Fu Long Nan, Wei Zheng, Wen Long Nan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 18
The Multifaceted Role of Macrophages in Oncolytic Virotherapy
Laura Hofman, Sean E. Lawler, Martine L.M. Lamfers
Viruses (2021) Vol. 13, Iss. 8, pp. 1570-1570
Open Access | Times Cited: 18
Fueling immune checkpoint blockade with oncolytic viruses: Current paradigms and challenges ahead
Shu‐Jin Li, Zhi‐Jun Sun
Cancer Letters (2022) Vol. 550, pp. 215937-215937
Closed Access | Times Cited: 11
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
Kyle M. Pierce, William R. Miklavcic, Kyle P. Cook, et al.
Nanomaterials (2021) Vol. 11, Iss. 11, pp. 3018-3018
Open Access | Times Cited: 15
Virus-Based Immuno-Oncology Models
Juliana Sitta, Pier Paolo Claudio, Candace M. Howard
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1441-1441
Open Access | Times Cited: 10
The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
Upasana Pathak, Ramprasad B. Pal, Nagesh Malik
Life (2023) Vol. 13, Iss. 8, pp. 1626-1626
Open Access | Times Cited: 4
The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect
Bo‐Kyoung Jung, Yong An, Sung Hoon Jang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top